| answer text |
<p>It is the responsibility of the integrated care boards (ICBs) to make available
appropriate provision to meet the health and care needs of their local population,
including access to attention deficit hyperactivity disorder (ADHD) treatment, in
line with relevant National Institute for Health and Care Excellence (NICE) guidance.
The NICE guideline on ADHD does not set out a timeframe within which medication for
ADHD should be provided. The Department has not made a specific assessment of the
implications on departmental policies of the average waiting time from diagnosis of
ADHD, to receiving a first medication prescription in Leeds.</p><p>In respect of the
adequacy of ADHD service provision nationally, in December 2023, NHS England initiated
a rapid piece of work to consider ADHD service provision within the National Health
Service. The initial phase of work identified challenges, including with current service
models and the ability to keep pace with demand. Following this initial review, NHS
England is establishing a new ADHD taskforce alongside the Government, to look at
ADHD service provision and its impact on patient experience. The new taskforce will
bring together expertise from across a broad range of sectors, including the NHS,
education, and justice, to better understand the challenges affecting people with
ADHD, and help provide a joined up approach in response to concerns around rising
demand for assessments and support.</p><p>Alongside the work of the taskforce, NHS
England has announced that it will continue to work with stakeholders to develop a
national ADHD data improvement plan, carry out more detailed work to understand the
provider and commissioning landscape, and capture examples from local health systems
which are trialling innovative ways of delivering ADHD services to ensure best practice
is captured and shared across the system.</p>
|
|
